Cargando…
Erythromycin as a Safe and Effective Treatment Option for Erythema Annulare Centrifugum
BACKGROUND: Erythema annulare centrifugum (EAC) is an inflammatory dermatosis with unknown etiology. It is usually self-limited, but chronic disease may be difficult to treat. We observed incidentally the therapeutic effect of erythromycin for EAC among patients taking erythromycin for other disease...
Autores principales: | Chuang, Fu-Chen, Lin, Shang-Hong, Wu, Wei-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601434/ https://www.ncbi.nlm.nih.gov/pubmed/26538713 http://dx.doi.org/10.4103/0019-5154.159633 |
Ejemplares similares
-
Erythema Annulare Centrifugum: Deep Variant with Vasculitis Like Histopathology
por: Nayak, Sudhir UK, et al.
Publicado: (2013) -
ERYTHEMA ANNULARE CENTRIFUGUM IN PREGNANCY
por: Senel, Engin, et al.
Publicado: (2010) -
Aceclofenac-Induced Erythema Annulare Centrifugum
por: Meena, Dilip, et al.
Publicado: (2018) -
Erythema annulare centrifugum in a child
por: Meloche, Laurence, et al.
Publicado: (2022) -
Tocilizumab-Induced Erythema Annulare Centrifugum
por: João, Ana Luísa, et al.
Publicado: (2022)